In vivo transfer of human hepatocyte growth factor gene accelerates re-endothelialization and inhibits neointimal formation after balloon injury in rat model
- 1 October 2000
- journal article
- acquired diseases
- Published by Springer Nature in Gene Therapy
- Vol. 7 (19) , 1664-1671
- https://doi.org/10.1038/sj.gt.3301284
Abstract
Although most therapeutic strategies to prevent restenosis are designed to inhibit vascular smooth muscle cell (VSMC) proliferation directly, VSMC proliferation might be indirectly inhibited by re-endothelialization, as endothelial cells secrete antiproliferative and antithrombotic substances. We hypothesized that application of an endothelium-specific growth factor to balloon-injured arteries could accelerate re-endothelialization, thereby attenuating intimal hyperplasia. In this study, we investigated in vivo gene transfer of human HGF that exclusively stimulated endothelial cells without replication of VSMC growth into injured vessels. Transfection of human HGF gene into rat balloon-injured carotid artery resulted in significant inhibition of neointimal formation up to at least 8 weeks after transfection, accompanied by detection of human immunoreactive HGF. Induction of re-endothelialization induced by overexpression of human HGF gene transfer into balloon-injured vessels is supported by several lines of evidence: (1) Administration of HGF vector, but not control vector, markedly inhibited neointimal formation, accompanied by a significant increase in vascular human and rat HGF concentrations. (2) Planimetric analysis demonstrated a significant increase in re-endothelialized area in arteries transfected with human HGF vector. (3) Induction of NO content in balloon-injured vessels transfected with human HGF vector was observed in accordance with the recovery of endothelial vasodilator properties in response to acetylcholine. As endogenous HGF expression in balloon-injured vessels was significantly decreased as compared with normal vessels, the present study demonstrated the successful inhibition of neointimal formation by transfection of human HGF gene as ‘cytokine supplement therapy’ in a rat balloon injury model.Keywords
This publication has 35 references indexed in Scilit:
- Negative Regulation of Local Hepatocyte Growth Factor Expression by Angiotensin II and Transforming Growth Factor-β in Blood VesselsHypertension, 1998
- Adenovirus-Mediated Gene Transfer of the Human TIMP-1 Gene Inhibits Smooth Muscle Cell Migration and Neointimal Formation in Human Saphenous VeinHuman Gene Therapy, 1998
- Hepatocyte Growth Factor (HGF) as a Tissue Organizer for Organogenesis and RegenerationBiochemical and Biophysical Research Communications, 1997
- A Vascular Modulator, Hepatocyte Growth Factor, Is Associated With Systolic PressureHypertension, 1996
- Arterial Gene Therapy for Restenosis. St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, MassachusettsHuman Gene Therapy, 1996
- Autocrine–Paracrine Effects of Overexpression of Hepatocyte Growth Factor Gene on Growth of Endothelial CellsBiochemical and Biophysical Research Communications, 1996
- Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty.Journal of Clinical Investigation, 1995
- Expression of Local Hepatocyte Growth Factor System in Vascular TissuesBiochemical and Biophysical Research Communications, 1995
- Novel in vitro gene transfer method for study of local modulators in vascular smooth muscle cells.Hypertension, 1993
- Regulation of Smooth Muscle Cell Growth in Injured ArteryJournal of Cardiovascular Pharmacology, 1989